These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9802364)

  • 21. Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy.
    Worm M; Lee HH; Kleine-Tebbe J; Hafner RP; Laidler P; Healey D; Buhot C; Verhoef A; Maillère B; Kay AB; Larché M
    J Allergy Clin Immunol; 2011 Jan; 127(1):89-97, 97.e1-14. PubMed ID: 21211644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Fel d 1 to FcgammaRI induces a novel variation of the T(H)2 response in subjects with cat allergy.
    Hulse KE; Reefer AJ; Engelhard VH; Satinover SM; Patrie JT; Chapman MD; Woodfolk JA
    J Allergy Clin Immunol; 2008 Mar; 121(3):756-762.e4. PubMed ID: 18086491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic cat allergen exposure induces a TH2 cell-dependent IgG4 response related to low sensitization.
    Renand A; Archila LD; McGinty J; Wambre E; Robinson D; Hales BJ; Thomas WR; Kwok WW
    J Allergy Clin Immunol; 2015 Dec; 136(6):1627-1635.e13. PubMed ID: 26371841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
    Blaser K
    Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat.
    Counsell CM; Bond JF; Ohman JL; Greenstein JL; Garman RD
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):884-94. PubMed ID: 8939151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.
    Alexander C; Tarzi M; Larché M; Kay AB
    Allergy; 2005 Oct; 60(10):1269-74. PubMed ID: 16134993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
    O'Brien RM; Byron KA; Varigos GA; Thomas WR
    Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.
    Zaleska A; Eiwegger T; Soyer O; van de Veen W; Rhyner C; Soyka MB; Bekpen C; Demiröz D; Treis A; Söllner S; Palomares O; Kwok WW; Rose H; Senti G; Kündig TM; Ozoren N; Jutel M; Akdis CA; Crameri R; Akdis M
    Allergy; 2014 Sep; 69(9):1162-70. PubMed ID: 24934402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-4 and IL-13 mRNA real-time PCR quantification on whole blood to assess allergic response.
    Ocmant A; Michils A; Schandené L; Peignois Y; Goldman M; Stordeur P
    Cytokine; 2005 Sep; 31(5):375-81. PubMed ID: 16051495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones.
    Fasler S; Aversa G; de Vries JE; Yssel H
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):521-30. PubMed ID: 9564806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of cat dander-specific T lymphocytes from atopic patients.
    van Neerven RJ; van de Pol MM; van Milligen FJ; Jansen HM; Aalberse RC; Kapsenberg ML
    J Immunol; 1994 Apr; 152(8):4203-10. PubMed ID: 8144980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and efficacy of ALLERVAX CAT in cat allergic patients.
    Maguire P; Nicodemus C; Robinson D; Aaronson D; Umetsu DT
    Clin Immunol; 1999 Dec; 93(3):222-31. PubMed ID: 10600332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects.
    Mark PG; Segal DB; Dallaire ML; Garman RD
    Clin Exp Allergy; 1996 Nov; 26(11):1316-28. PubMed ID: 8955581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chimeric human-cat Fcgamma-Fel d1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen.
    Terada T; Zhang K; Belperio J; Londhe V; Saxon A
    Clin Immunol; 2006 Jul; 120(1):45-56. PubMed ID: 16473552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma.
    Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T
    J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of hypoallergens applied to the major cat allergen Fel d 1.
    Saarne T; Kaiser L; Grönlund H; Rasool O; Gafvelin G; van Hage-Hamsten M
    Clin Exp Allergy; 2005 May; 35(5):657-63. PubMed ID: 15898990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study.
    Smith TR; Alexander C; Kay AB; Larché M; Robinson DS
    Allergy; 2004 Oct; 59(10):1097-101. PubMed ID: 15355469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgE and IgG binding patterns and T-cell recognition of Fel d 1 and non-Fel d 1 cat allergens.
    Hales BJ; Chai LY; Hazell L; Elliot CE; Stone S; O'Neil SE; Smith WA; Thomas WR
    J Allergy Clin Immunol Pract; 2013; 1(6):656-65.e1-5. PubMed ID: 24565714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of cat allergy with T-cell reactive peptides.
    Norman PS; Ohman JL; Long AA; Creticos PS; Gefter MA; Shaked Z; Wood RA; Eggleston PA; Hafner KB; Rao P; Lichtenstein LM; Jones NH; Nicodemus CF
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1623-8. PubMed ID: 8970345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.